2 chapters across the catalog
A federal judge has restructured the timeline for the FDA to release Pfizer vaccine trial documents, requiring 20,000 pages to be released monthly through April. Concurrently, Pfizer has added new language to its financial earnings reports regarding risks associated with preclinical and clinical safety data. These disclosures follow legal pressure to increase transparency regarding the vaccine's original approval process.
FDA Pfizer Data Lawsuit, 2076 Release Timeline
The FDA requests a federal judge's permission to delay the full release of Pfizer's vaccine trial data until the year 2076. The agency claims it can only process 500 pages per month of the 329,000-page document cache. This delay is compared to "document dumping" tactics used in corporate litigation to overwhelm opponents and hide relevant information.
